Tuesday, November 13, 2012

• Santarus and VeroScience Announce Publication of New Analysis of CYCLOSET (bromocriptine mesylate) Cardiovascular Data in the Journal of the American Heart AssociationBusiness Wire (Tue, Nov 13)

Saturday, November 10, 2012

• Santarus Beats on Both Top and Bottom Linesat Motley Fool (Sat, Nov 10)

Thursday, November 8, 2012

• Why Santarus' Shares Vaulted Higherat Motley Fool (Thu, Nov 8)
• 5 Under-$10 Stocks Set to Trade Higher in Novemberat TheStreet (Thu, Nov 8)
• SANTARUS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)

Wednesday, November 7, 2012

• Santarus' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Nov 7)
• SANTARUS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Nov 7)
• Santarus Reports Third Quarter 2012 Financial ResultsBusiness Wire (Wed, Nov 7)
• Santarus and Pharming Announce Positive Top-Line Phase III Results for RUCONEST in Acute Hereditary AngioedemaBusiness Wire (Wed, Nov 7)

Monday, November 5, 2012

• Santarus to Present at November Investor ConferencesBusiness Wire (Mon, Nov 5)

Thursday, October 18, 2012

• Using Options To Benefit From The Binary Nature Of FDA Decisionsat Seeking Alpha (Thu, Oct 18)

Wednesday, October 10, 2012

• SANTARUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Wed, Oct 10)

Thursday, September 27, 2012

• Santarus Announces Study Results and 2 Stocks that Have Hit 52-Week Highsat Wall St. Cheat Sheet (Thu, Sep 27)

Tuesday, September 25, 2012

• Under Armour Plagued With Supply Constraints and 4 Stock Analyses Not to Ignoreat Wall St. Cheat Sheet (Tue, Sep 25)
• Cosmo Pharma CEO Sees $1.5 Billion Dye Luring Buyer by 2013at Bloomberg (Tue, Sep 25)

Thursday, September 20, 2012

• Biotech Stock Valuations and the Affordable Care Act: Interview with UBS Investment Bank Expert Analyst Identifies Top Winners and LosersWall Street Transcript (Thu, Sep 20)

Wednesday, September 19, 2012

• Santarus' CEO Presents at UBS Global Life Sciences Conference (Transcript )at Seeking Alpha (Wed, Sep 19)

Thursday, September 13, 2012

• Healthcare Business Recap: Santarus’s Good NEWS, AstraZeneca Issues BONDSat Wall St. Cheat Sheet (Thu, Sep 13)

Wednesday, September 12, 2012

• Visa REITERATED at Outperform and 4 Reiterated Ratings to See Nowat Wall St. Cheat Sheet (Wed, Sep 12)
• Analyst Bearish on Chesapeake Near-Term and 4 Stock Insights to Watch Nowat Wall St. Cheat Sheet (Wed, Sep 12)
• SANTARUS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Sep 12)

Tuesday, September 11, 2012

• Santarus says diarrhea drug meets goal in studyAP (Tue, Sep 11)
• Santarus announces positive top-line phase 3 results for Rifamycin SV MMXat theflyonthewall.com (Tue, Sep 11)

Monday, September 10, 2012

• Santarus, Par, Apple, Google: Intellectual Propertyat Bloomberg (Mon, Sep 10)
• Santarus Can Pursue Some Patent Claims Over Zegerid Copyat Bloomberg (Mon, Sep 10)

Add SNTS News to My Yahoo!